| Ms Romelle Holmgren Lysenko, LCSW | |
|
16 Gifford Rd, Somerset, NJ 08873-2306 | |
| (848) 565-7052 | |
| Not Available |
| Full Name | Ms Romelle Holmgren Lysenko |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 16 Years |
| Location | 16 Gifford Rd, Somerset, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417290420 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC05516700 (New Jersey) | Primary |
| Entity Name | Trinity Counseling Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093871394 PECOS PAC ID: 1456486208 Enrollment ID: O20100413000026 |
News Archive
U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).
New research and guidance in the American Journal of Preventive Medicine, published by Elsevier, focus on critical topics pertaining to community and individual health during the COVID-19 epidemic.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will present final data from a Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was sustained well beyond the end of therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Romelle Holmgren Lysenko, LCSW 16 Gifford Rd, Somerset, NJ 08873-2306 Ph: (848) 565-7052 | Ms Romelle Holmgren Lysenko, LCSW 16 Gifford Rd, Somerset, NJ 08873-2306 Ph: (848) 565-7052 |
News Archive
U.S. drug reviewers might limit the use of a Seattle Genetics Inc's experimental blood cancer drug due to the narrow scope of its clinical trials. According to papers released Tuesday by the Food and Drug Administration (FDA), it requests an advisory panel to consider the drug, under the proposed trade name Adcetris known chemically as brentuximab vedotin, for use in previously treated patients with Hodgkin's lymphoma and anaplastic large cell lymphoma (ALCL).
New research and guidance in the American Journal of Preventive Medicine, published by Elsevier, focus on critical topics pertaining to community and individual health during the COVID-19 epidemic.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will present final data from a Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was sustained well beyond the end of therapy.
› Verified 6 days ago
Naomi Lasky, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 18 Heather Dr, Somerset, NJ 08873 Phone: 908-698-2571 | |
Mrs. Laura Rose Stern, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 Clyde Rd, Suite 102, Somerset, NJ 08873 Phone: 908-720-1776 Fax: 732-521-5113 | |
Nancy Gable, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29 Clyde Rd Ste 201, Somerset, NJ 08873 Phone: 908-227-5641 | |
Ms. Jessica Sarah Kenyon, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 904 Allen Rd, Somerset, NJ 08873 Phone: 848-391-6008 | |
Mrs. Lorraine Gallagher, MSW LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 7 Clubhouse Rd, Somerset, NJ 08873 Phone: 732-873-3482 | |
Denise Geffke-ramos, LCSW, LCADC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 27 Lake Ave, Somerset, NJ 08873 Phone: 201-417-3778 | |
Yushi Wang, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1075 Easton Ave Ste 11268, Somerset, NJ 08873 Phone: 908-368-1768 |